Eduardo Rojas is a seasoned program management professional with extensive experience in the biopharmaceutical industry. Currently serving as Senior Director of Program Management at Neuron23 since May 2024, Rojas previously held key roles at Chinook Therapeutics, where leadership as Director of Program Management and Portfolio Integration was demonstrated, particularly during the company's acquisition by Novartis. Rojas has managed drug development teams at Heron Therapeutics from phase 2/3 to commercial launch and has led significant initiatives at companies like Scimitar Inc., Illumina, Amylin Pharmaceuticals, and Amgen, focusing on project management excellence and operational improvements. Educational credentials include an MBA from the University of Michigan and a degree in Industrial and Systems Engineering from Tecnológico de Monterrey.
This person is not in any teams
This person is not in any offices